Credit Suisse Ag Nektar Therapeutics Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.64 - $3.15 $22 - $110	35 Added 0.02%	174,859 $122,000
Q4 2022 Feb 13, 2023	BUY	$2.03 - $4.28 $4,076 - $8,594	2,008 Added 1.16%	174,824 $395,000
Q3 2022 Nov 10, 2022	SELL	$3.04 - $5.14 $14,537 - $24,579	-4,782 Reduced 2.69%	172,816 $553,000
Q2 2022 Aug 12, 2022	SELL	$3.17 - $6.17 $91,660 - $178,405	-28,915 Reduced 14.0%	177,598 $674,000
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $187,258 - $617,592	45,014 Added 27.87%	206,513 $1.11 Million

Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $269,352 - $457,875	-24,871 Reduced 13.34%	161,499 $2.18 Million
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $163,401 - $235,537	12,502 Added 7.19%	186,370 $3.35 Million
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $597,495 - $737,827	-36,168 Reduced 17.22%	173,868 $2.98 Million
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $512,581 - $788,063	-30,953 Reduced 12.84%	210,036 $4.2 Million
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $9.12 Million - $11 Million	-578,353 Reduced 70.59%	240,989 $4.1 Million
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $2.57 Million - $3.84 Million	-154,749 Reduced 15.89%	819,342 $13.6 Million
Q2 2020 Aug 12, 2020	SELL	$16.86 - $23.44 $3.9 Million - $5.42 Million	-231,135 Reduced 19.18%	974,091 $22.6 Million
Q1 2020 May 13, 2020	BUY	$14.47 - $27.96 $7.7 Million - $14.9 Million	532,088 Added 79.05%	1,205,226 $21.5 Million
Q4 2019 Feb 12, 2020	SELL	$15.87 - $23.12 $1.95 Million - $2.84 Million	-122,782 Reduced 15.43%	673,138 $14.5 Million
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $3.82 Million - $8.18 Million	225,649 Added 39.57%	795,920 $14.5 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $2.98 Million - $3.49 Million	96,214 Added 20.3%	570,271 $20.3 Million
Q1 2019 May 14, 2019	SELL	$31.58 - $46.35 $15,663 - $22,989	-496 Reduced 0.1%	474,057 $15.9 Million
Q4 2018 Feb 13, 2019	SELL	$30.43 - $56.65 $554,647 - $1.03 Million	-18,227 Reduced 3.7%	474,553 $15.6 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $1.58 Million - $2.33 Million	33,985 Added 7.41%	492,780 $30 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $3.09 Million - $6.98 Million	66,810 Added 17.04%	458,795 $22.4 Million
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $3.11 Million - $5.88 Million	54,200 Added 16.05%	391,985 $41.7 Million
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $661,157 - $1.74 Million	-28,721 Reduced 7.84%	337,785 $20.2 Million
Q3 2017 Nov 14, 2017	BUY	$17.79 - $24.0 $1.29 Million - $1.74 Million	72,363 Added 24.6%	366,506 $8.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	294,143	294,143 $5.75 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$23.7 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$15.5 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$9.76 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.99 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$7.58 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account